spinout | GenomeWeb

spinout

The Bridget Ogilvie Building will house sequencing facilities, and the Biodata Innovation Centre will host genomic startups.

ReadCoor is currently using its its technology to map neural circuits in the brain and has projects in the pipeline related to oncology and infectious disease.

Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.

The molecular diagnostics developer will use the money to continue expanding its commercial presence in the cancer diagnostics market.

OncoCyte has spun off as a publicly traded company from BioTime and has begun trading on the NYSE MKT under the symbol OCX.

OmniSeq's goal is to make cancer genomic testing available to institutions, including comprehensive cancer centers, oncology practices, and community oncology groups.

NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market Wednesday that its board of directors has approved the separation of Keysight Technologies, the new name for its electronic measurement subsidiary, from the firm and has named a successor to current CEO Bill Sullivan.

NEW YORK (GenomeWeb) – Biocartis announced today that it has raised €64.5 million ($84 million) in a round of private financing.

NEW YORK (GenomeWeb News) – Fitch Ratings today affirmed its long-term rating on Agilent Technologies' debt at 'BBB+' and revised its outlook to stable from positive, following Agilent's announcement earlier in the day that it would

NEW YORK (GenomeWeb News) – Agilent Technologies announced today that it will split into two publicly-traded companies — one focused on its life science and diagnostics business and the other on its electronic measurement business.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.